Evidence map›Paper›PMID 26060895›Full record

ArticleAnnals of the New York Academy of Sciences2015

Natural and induced B-1 cell immunity to infections raises questions of nature versus nurture.

Nicole Baumgarth, Elizabeth E Waffarn, Trang T T Nguyen

Abstract read
In one paragraph

Article in Annals of the New York Academy of Sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Do human B-1 lymphocytes truly exist?Frontiers in immunology · 2026
    Review
  2. Article
  3. Article
  4. Anti-Microorganisms · 2022
    Review
  5. Sex Influences Age-Related Changes in Natural Antibodies and CD5Journal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  6. Review
  7. Sphingosine-1-Phosphate Receptor Type 4 (S1PInternational journal of molecular sciences · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. The Promise of Anti-idiotype Revisited.Frontiers in immunology · 2019
    Review
  17. Article
  18. Review
  19. A Novel Role for C5a in B-1 Cell Homeostasis.Frontiers in immunology · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nicole BaumgarthCenter for Comparative Medicine, University of California, Davis, California.
Elizabeth E WaffarnCenter for Comparative Medicine, University of California, Davis, California.
Trang T T NguyenCenter for Comparative Medicine, University of California, Davis, California.
University of California, Davis · US

Funding

Virus-induced Cell Fate Decisions in Anti-Viral ImmunityU19AI109962 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RANDALL, TROY D · 2014 to 2018
$11.6M
Regulation of Humoral Immunity to Influenza VirusR01AI051354 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI BAUMGARTH, NICOLE · 2002 to 2012
$3.0M
Early Regulation of Immunity in the Respiratory TractR01AI055881 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI BAUMGARTH, NICOLE · 2003 to 2007
$1.5M
Long-lived B cell Immunity in the Respiratory TractR01AI085568 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMGARTH, NICOLE · 2010 to 2013
$1.5M
NIAID NIH HHS AI085568NIAID NIH HHS R01 AI051354NIAID NIH HHS R01 AI055881NIAID NIH HHS R01 AI085568NIAID NIH HHS U19 AI109962
6 · The paper itself

Abstract

Mouse B-1 cells are not only major producers of steady-state natural antibodies but also rapid responders to infections and inflammation. These discrete functions may be the outcomes of distinct environmental or developmental triggers that drive B-1 cells toward IgM production or an effector cell fate. Alternatively, distinct B-1 cell subsets may exist, which differ in their functional plasticity. In this paper, we summarize existing data suggesting that B-1 cells form a heterogeneous group of cells with distinct developmental requirements and nonoverlapping functions. Most spleen B-1 cells differ in development from that of bone marrow and peritoneal cavity B-1 cells, in that they develop in the absence of natural IgM. Functional heterogeneity is revealed by findings that B-1 cells in the bone marrow and spleen, but not the peritoneal cavity, generate natural serum IgM, while the latter are rapid responders to inflammatory and infectious insults, resulting in their relocation to secondary lymphoid tissues. A clearer understanding of the developmental and functional differences within the B-1 cell pool may reveal how they might be harnessed for prophylaxis or therapy.

Indexed as

AnimalsB-Lymphocyte SubsetsBone Marrow CellsCommunicable DiseasesFemaleImmunity, CellularMaleMiceMice, 129 StrainMice, Inbred C57BLSpleenB cell subsetsIgMinfluenza virus infectionsnatural antibodies

Identifiers

PMID26060895
PMCPMC4881423
OpenAlexW1893984782

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.